OR4F17 was also not a potential biomarker for discriminating CHB from HBV-LC with AUC of 0.534 or for HBV-HCC from healthy controls with AUC of 0.736 (95% CI not shown). The gene discussed is OR4F17; the disease is hepatocellular carcinoma.